Myriad Genetics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Myriad Genetics Stock Summary

Myriad Genetics competes with Guardant Health, Caredx, Castle Biosciences, Sotera Health, and Neogen. Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company was founded in 1991 and is headquartered in Salt Lake City, Utah. Myriad Genetics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2400 people.

Myriad Genetics Key Financial Ratios

Myriad Genetics Key Balance Sheet Accounts

Myriad Genetics Key Income Statement Accounts

Myriad Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Myriad Genetics's current stock value. Our valuation model uses many indicators to compare Myriad Genetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Myriad Genetics competition to find correlations between indicators driving Myriad Genetics's intrinsic value. More Info.Myriad Genetics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Myriad Genetics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Myriad Genetics' earnings, one of the primary drivers of an investment's value.

Myriad Genetics' Earnings Breakdown by Geography

Myriad Genetics Systematic Risk

Today, most investors in Myriad Genetics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Myriad Genetics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Myriad Genetics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Myriad Genetics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Myriad Genetics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Myriad Genetics based on widely used predictive technical indicators. In general, we focus on analyzing Myriad Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Myriad Genetics's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.